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Aquaporin 1 (AQP1) is the major water channel in the renal proximal
tubule (PT) and thin descending limb of Henle, but its regulation
remains elusive. Here, we investigated the effect of ANG II, a key
mediator of body water homeostasis, on AQP1 expression in immor-
talized rat proximal tubule cells (IRPTC) and rat kidney. Real-time
PCR on IRPTC exposed to ANG II for 12 h revealed a biphasic effect
AQP1 mRNA increased dose dependently in response to 1012 to
108 M ANG II but decreased by 50% with 107 M ANG II. The
twofold increase of AQP1 mRNA in the presence of 108 M ANG II
was abolished by the AT1 receptor blocker losartan. Hypertonicity due
to either NaCl or mannitol also upregulated AQP1 mRNA by three-
and twofold, respectively. Immunocytochemistry and Western blot-
ting revealed a two- to threefold increase in AQP1 protein expression
in IRPTC exposed concomitantly to ANG II (108M) and hypertonic
medium (either NaCl or mannitol), indicating that these stimuli were
not additive. Three-dimensional reconstruction of confocal images
suggested that AQP1 expression was increased by ANG II in both the
apical and basolateral poles of IRPTC. In vivo studies showed that
short-term ANG II infusion had a diuretic effect, while this effect was
attenuated after several days of ANG II infusion. After 10 days, we
observed a twofold increase in AQP1 expression in the PT and thin
descending limb of Henle of ANG II-infused rats that was abolished
when rats were treated with the selective AT1-receptor antagonist
olmesartan. Thus ANG II increases AQP1 expression in vitro and
in vivo via direct interaction with the AT1 receptor, providing an
important regulatory mechanism to link PT water reabsorption to
body fluid homeostasis via the renin-angiotensin system.
renin angiotensin system; proximal tubule
ANG II, the major effector of the renin-angiotensin system
(RAS) (37), plays direct and indirect roles in water and salt
homeostasis. In addition to its regulation of renal blood
flow, glomerular filtration, and aldosterone secretion, ANG
II binding to ANG II type 1 receptors (AT1R) located in
kidney proximal tubules additionally modulates sodium and
bicarbonate reabsorption (22). AT1R is broadly distributed in
the kidney vasculature and the proximal tubule, medullary
thick ascending limb, and all segments of the collecting duct
(45–47). Lee et al. (39) demonstrated that ANG II can poten-
tiate aquaporin 2 (AQP2) membrane insertion in response to
vasopressin and that this effect can be blocked by candesartan,
an AT1R blocker, in primary cultured rat inner medullary
collecting duct cells. Furthermore, ANG II was also shown to
downregulate the expression of the urea transporter UT-A1, as
well as that of the vasopressin-sensitive water channel AQP2
(35) in the rat kidney. In addition, ANG II upregulates vaso-
pressin receptor type 2 (V2R) expression in the rat (68). Thus
ANG II appears to play an important role in water reabsorption
via its direct and indirect actions on regulation of the vaso-
pressin-sensitive water channel AQP2 and other components of
the urinary concentrating mechanism. However, the relation-
ship between ANG II and other water channels in the kidney,
including AQP1, is not well established.
The lack of urine concentrating ability observed in AQP1
knockout mice (52, 57, 69) highlights the importance of this
transmembrane water channel protein, which is present in
plasma membranes of several transporting epithelia, including
the luminal and basolateral domains of renal proximal tubule
and thin descending limb of Henle (TDLH) cells (23, 51, 54).
Together, these two nephron segments are responsible for
reabsorbing 80% of the fluid from the glomerular filtrate (36).
Most of the remaining 20% is reabsorbed by AQP2 water
channels in the distal nephron and collecting ducts.
In contrast to AQP2, the potential mechanisms by which
AQP1 is regulated in renal proximal tubule cells remain largely
unexplored. It has been generally thought that the effects of
ANG II on proximal tubule fluid transport are secondary to
altered electrolyte transport. While hypertonic NaCl has been
shown to upregulate AQP1 expression in cultured renal epi-
thelial cells (31), a potential role for ANG II in modulation of
the AQP1 water channel in proximal tubule cells has not been
investigated. Wintour et al. (67) demonstrated an increase of
AQP1 mRNA in the sheep fetal kidney after infusion of ANG
I. Additionally, Imai et al. (27) demonstrated suppression of
AQP1 in peritoneal membranes of Wistar-Kyoto rats following
treatment with either an angiotensin converting enzyme (ACE)
inhibitor or an AT1R antagonist (ARB), suggesting that the
RAS plays an important role in the regulation of water trans-
Address for reprint requests and other correspondence: R. Bouley, Center for
Systems Biology, Program in Membrane Biology, Nephrology Division, Massa-
chusetts General Hospital, Harvard Medical School, CPZN 8150, 185 Cambridge
St., Boston, MA 02114 (e-mail: Bouley.Richard@mgh.harvard.edu).
Am J Physiol Renal Physiol 297: F1575–F1586, 2009.
First published September 23, 2009; doi:10.1152/ajprenal.90762.2008.
0363-6127/09 $8.00 Copyright © 2009 the American Physiological Societyhttp://www.ajprenal.org F1575
port in the peritoneum. Studies (5, 10, 20, 43, 59) using
isolated perfused tubules or micropuncture have demonstrated
substantial effects of ANG II on salt and water transport in the
proximal tubule. Data from such studies (20, 32, 41, 56)
suggest that not only is the RAS important in the regulation of
hemodynamics but also in sodium reabsorption and tubuloglo-
merular feedback.
The present study aimed to examine the influence of ANG II
on AQP1 expression in proximal tubule cells and to determine
whether sodium chloride in the presence and absence of ANG
II alters AQP1 expression. The effect of ANG II was studied in
vitro using immortalized rat proximal tubule epithelial cells
(IRPTC), which endogenously express AQP1 and all compo-
nents of the RAS (61, 62) and in vivo using Sprague-Dawley
rats. Our results indicate that both ANG II and hypertonicity
modulate AQP1 mRNA and protein expression in a time- and
dose-dependent manner in proximal tubules.
MATERIALS AND METHODS
Cell culture, reagents, and antibodies. All cell culture reagents
were purchased from Invitrogen (Carlsbad, CA), and ANG II and
inorganic salts were purchased from Sigma (St. Louis, MO). For this
study, we used IRPTC to study the effect of the ANG II or NaCl
exposure on AQP1 mRNA and protein expression (61, 62). The cell
line was maintained in low glucose (5.5 mM), low sodium (81 mM)
DMEM containing 25 mM HEPES. The cell culture medium was
supplemented with 5% FCS, 100 U/ml penicillin, 100 g/ml strepto-
mycin, and 0.01 mM nonessential amino acids. In some experiments,
as indicated below, NaCl was added to the low sodium medium to
mimic normal serum content of 150 mM or to raise the NaCl
concentration to 220 mM.
Before initiation of experiments, IRPTC were preincubated in
serum-free medium (DMEM) containing 84 mM NaCl, and 0.5%
BSA for 24 h. ANG II was then added, and cells were incubated for
1, 6, and 12 h at 37°C in the presence of 0, 1012, 109, 108, and
107 M ANG II. Losartan, an AT1R blocker, and PD123319 (10 M),
an AT2R blocker, were used as indicated below.
In addition, IRPTC were incubated in medium containing various
concentrations of NaCl to study the effect of hypertonicity on AQP1
mRNA and AQP1 protein expression. Cells were incubated with low
glucose, low sodium DMEM into which 90, 150, and 220 mM of
NaCl had been added. Thus cells were exposed to normal (310
mosM), medium (415 mosM), and high osmolarity (550 mosM). To
distinguish between the hyperosmotic and tonicity effects of NaCl,
DMEM containing 440 mM of mannitol (740 mosM) was also used.
The effects of combined exposure for 12 h at 37°C to hyperosmotic
medium and ANG II (108 M) were also studied.
Animal treatment. Animal experiments were approved by the
Massachusetts General Hospital Institutional Committee on Research
Animal Care in accordance with the National Institutes of Health’s
Guide for the Care and Use of Laboratory Animals. Male Sprague-
Dawley rats (Charles River Laboratories, Wilmington, MA) were
housed for 24 h in metabolic cages immediately before treatment (day
0). The day of the experiment rats were anesthetized with isofluorane,
and Alzet osmotic minipumps (Durect, Cupertino, CA) delivering
either a solution of acetic acid 5% (sham) or ANG II diluted in acetic
acid 5% solution (80 ng/min) were implanted subcutaneously on the
back of the rats. A group of ANG II-treated rats received food
containing a nonpeptidic ANG II antagonist (olmesartan, 5 mg/day) as
previously described (37). Animals were again housed in metabolic
cages and maintained in a temperature-controlled room regulated on a
12-h light-dark cycle with free access to the water. All animals were
fed with ground pellets mixed or not mixed with olmesartan (Prolab
IsoproRMH3000; LabDiet, Richmond, IN). Mean blood pressures
were measured in conscious rats using tail-cuff plethysmography at
day 10 (CODA System; Kent Scientific, Torrington, CT). Urine and
blood osmolarities were measured using an osmometer (Wescor,
Logan, UT). At the termination of treatment, animals were eutha-
nized, and one kidney was harvested for Western blot analysis, while
the other was fixed for immunocytochemistry.
mRNA quantification by RT-PCR. IRPTC total RNA was isolated
using TRIzol reagent (Invitrogen) according to the manufacturer’s
instructions. The RNA was treated with DNase I (Ambion, Austin,
TX) to eliminate contamination by genomic DNA, and the final RNA
concentration was standardized to 0.75 g/l. The integrity of the
RNA was assessed by agarose gel electrophoresis. One-step real-time
RT-PCR was carried out on a real-time thermal cycler (iCycler;
Bio-Rad Life Sciences, Hercules, CA) using a QuantiTect SYBR
Green RT-PCR kit (Qiagen, Valencia, CA). The method allows the
reverse transcription and PCR to be carried out in a single step in the
same reaction tube. The fluorescent dye SYBR Green I was included
in the PCR master mix; in addition, the reaction was spiked with 0.5
l of 1 M fluorescein for background reference. The threshold cycle
number (Ct) for RT-PCR was set by the cycler software.
Fig. 1. Real-time PCR shows that ANG II has a biphasic effect on aquaporin
1 (AQP1) mRNA regulation. Immortalized rat proximal tubule cells (IRPTC)
were incubated in the absence or presence of various concentrations of ANG
II for 12 h, and AQP1 mRNA expression was assessed by real-time PCR.
AQP1 mRNA levels are reported as values relative to the level of AQP1
mRNA in the absence of ANG II [control (CT)]. AQP1 mRNA level expres-
sion was upregulated in the presence of ANG II (108 and 109 M), while it
is downregulated in the presence of a higher concentration of ANG II (107
M). Data are means  SD; n  8. *P  0.001.
Fig. 2. Real-time PCR demonstrates that losartan (Los) inhibits the ANG
II-induced increase in AQP1 mRNA . Real-time PCR analysis showed an
increase in the level of AQP1 mRNA in IRPTC treated 12 h in the presence of
ANG II (108 M) compared with the level of AQP1 mRNA in untreated cells
(CT). This increase in AQP1 mRNA expression was abolished when ANG
II-treated cells were also incubated in the presence of 105 M losartan (Los),
a selective ANG II receptor type 1 antagonist. Losartan alone produced a
significantly decreased of AQP1 mRNA level in IRPTC. Data are means 
SD; n  8. *P  0.001.
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PCR primers (22–24 bp) for AQP1 (AQP1 sense: 5-GCT GTC
ATG TAT ATC ATC GCC CAG-3; and AQP1 anti-sense: 5-AGG
TCA TTT CGG CCA AGT GAG T-3) and GAPDH (GAPDH sense:
5-TGT TCC AGT ATG ACT CTA CCC ACG-3; and antisense:
5-GAA GAT GGT GAT TGG TTT CCC GTT-3) were designed
using commercial software (Beacon Designer; Bio-Rad Life Sciences)
to produce an amplicon length of 107 bp. Optimal primer concentra-
tion for PCR was determined separately for each primer pair. Each
reaction was run in triplicate, and reaction tubes with target primers
and those with GAPDH primers were always included in the same
PCR run. To test primer efficiencies, the one-step RT-PCR was run
with each target primer/GAPDH primer combination on an mRNA
template dilution series up to a dilution factor of 1:100. The Ct
{Ct[target]  Ct[GAPDH]} over the dilution range was constant for
each primer pair, indicating equal primer efficiencies of the target and
reference (GAPDH) primers, as required for the comparative Ct
method (44) .
Relative quantification was achieved by the comparative 2(Ct)
(44). The relative increase/decrease (fold-induction/repression) of mRNA
of target  in the experimental group was calculated using the control
group as the calibrator: 2(Ct), where (Ct) is: {Ct.x[AQP1] 
Ct.GAPDH[AQP1]}  {Ct.x[control]  Ct.GAPDH[control]}.
Immunocytochemistry. Immunocytochemistry studies were per-
formed on 90% confluent cells grown on 12-mm coverslips. IRPTC
Fig. 3. Confocal microscopy reveals AQP1 increases
both apically and basolaterally upon stimulation with
ANG II (108 M). A–D: maximum projection and XZ
slice (taken at the white line) of three-dimensional
reconstructions of IRPTC incubated in the absence (A
and C) or the presence of ANG II (108 M; B and D) for
12 h. The Z projections reveal an increase of AQP1 (red)
staining on both apical regions [above the zonula occlu-
dens-1 (green) staining] as well as in basolateral mem-
branes in the presence of ANG II. Staining intensity of
AQP1 in a single midnuclear confocal plane is illus-
trated for untreated IRPTC (E) or cells treated with
ANG II (F; 108 M) for 12 h. G: densitometric quan-
tification revealed that membrane fluorescence was
higher in ANG II-treated cells compared with untreated
(CT) cells. Data are means  SE; n  3. *P  0.05.
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were grown and treated with ANG II or NaCl as described in Cell
culture, reagents, and antibodies. After treatment, cells were fixed for
20 min at room temperature in 4% paraformaldehyde (Electron
Microscopy Sciences, Hatfield, PA), diluted in 0.1 M phosphate
buffer, pH 7.4. After three washes in PBS pH 7.4, cells were
permeabilized for 3 min with 0.1% Triton X-100 diluted in PBS.
Nonspecific staining was blocked by incubating cells with PBS
containing 0.5% BSA. Fixed cells were then incubated for 1 h in
mouse-anti-zonula occludens-1 antibody diluted 1:10 in PBS (Chemi-
con, Temecula, CA). An affinity purified polyclonal rabbit anti-serum
raised against AQP1 protein purified from human red blood cells and
characterized as previously described (54) was subsequently applied
at a dilution of 1:100 in PBS for 1 h. After incubation, cells were
washed three times with PBS. The cells were then incubated for 1 h
with a mixture of both Alexa 488-conjugated goat anti-rabbit IgG (3
g/ml; Molecular Probes, Eugene, OR) and indocarbocyanine (Cy3)
conjugated goat anti-mouse IgG (1.25 g/ml; Jackson ImmunoRe-
search, West Grove, PA). Coverslips were then mounted on slides in
1:1 Vectashield:0.3 mM Tris HCl pH 8.0 (Vector Labs, Burlingame,
CA) to retard quenching of the fluorescence signal. Images were
acquired using a Nikon Eclipse TE2000-U inverted microscope
equipped with a PerkinElmer UltraVIEW spinning disc confocal and
a Nikon Plan Apo 60 1.45 NA objective lens. Z slices were captured
at 0.1-m intervals at an exposure time of 1 s. Three-dimensional
(3D) reconstructions were made using the Volocity (Improvision,
Waltham, MA) software package, and figures were prepared using
Adobe Photoshop (Adobe, Newton, MA).
In parallel, a second series of coverslips were treated as described
above. After fixation, the cells were stained with only the rabbit
anti-AQP1 antibody followed by Cy3-conjugated goat-anti-rabbit IgG
antibody (1.5 g/ml; Jackson ImmunoResearch). Images were taken
using a Zeiss Radiance 2000 confocal microscope (Zeiss, Thornwood,
NY) with a Zeiss 63 1.4 NA objective lens. Quantification of AQP1
in cells was performed using IPlab Spectrum software (BD Bio-
sciences) on confocal images. The fluorescence of more than 50 cells
from 3 independent experiments was estimated. The mean pixel
intensity of the basolateral membrane of cells was quantified, and the
background was corrected by the subtraction of the mean pixel
intensity of the nucleus. Only cells in the middle of the field of view
were quantified to ensure conditions of even illumination. Results
were expressed as the amount of fluorescence per unit area, with the
control value normalized to 100%.
SDS-PAGE and Western blotting of cell membrane preparations.
Cells were cultured in 60-mm Petri dishes and treated as described in
Cell culture, reagents, and antibodies. After ANG II or NaCl treat-
ment, the confluent cells were washed twice with cold PBS to remove
culture medium. Cells were lysed in 150 l of cold RIPA buffer
(Boston Bioproducts, Boston, MA) supplemented with protease in-
hibitor (Roche Diagnostics). Cell debris was pelleted at 13,000 g. The
concentration of the solubilized protein from the supernatant was
determined using the BCA protein assay (Pierce Biotechnology,
Rockford, IL). Membrane preparations were solubilized by heating at
70°C for 10 min in the reducing sample buffer (Invitrogen). Proteins
(15 g) were separated by electrophoresis on NuPAGE 4–12%
Bis-Tris gel following the manufacturer’s protocol (Invitrogen), fol-
lowing which proteins were electroblotted on polyvinylidene difluo-
ride filters (90 min, 4°C, 100 V; Bio-Rad). Subsequently, the mem-
branes were blocked in blotting buffer PBS Tween 0.1% and 5%
nonfat dry milk. Membranes were incubated in the presence of
primary antibody, immunopurified rabbit-anti-AQP1 antibody diluted
1:500 in PBS, 0.1% Tween, and 3% nonfat dry milk. After 2 h of
incubation and four washes in PBS Tween 0.1% solution, the mem-
brane was incubated for 1 h with 0.5 g/ml horseradish peroxidase
(HRP)-conjugated donkey anti-rabbit antibody (Jackson Immuno-
Research). After four washes, the peroxidase activity was detected
with ECL enhanced chemiluminescence system (PerkinElmer, Bos-
ton, MA) and Biomax XAR film (PerkinElmer). After exposure, the
membrane was acid stripped with 0.2 M glycine-HCl pH 2.5, Tween
0.05% for 1 h and reincubated with mouse anti-actin antibody (0.1
g/ml Chemicon International, Temecula, CA) and a HRP-conjugated
donkey anti-mouse antibody (0.8 g/ml; Jackson ImmunoResearch)
as loading control. The band intensities were quantified from scanned
film images using IPlab Spectrum software (BD Biosciences).
Immunocytochemistry on rat kidney sections. Alzet osmotic
minipumps (Durect, Cupertino, CA) delivering either a solution of
acetic acid 5% (sham) or ANG II diluted in acetic acid 5% solution
(80 ng/min) were implanted in rats. A group of ANG II-treated rats
received food containing a nonpeptidic ANG II antagonist (olmesar-
tan, 5 mg/day) as described in Animal treatments and in a previous
study (37). After treatment, animals were euthanized, and then kid-
neys were harvested, fixed, and embedded in paraffin as previously
described (37). Four-micrometer kidney sections mounted on slides
were heated for 1 h at 65°C before being deparaffinized in xylene and
rehydrated through a series of alcohol baths (100, 75, 50, and 25%).
Kidney sections were washed three times in PBS before blocking for
20 min with PBS, BSA 1%. The kidney sections were then incubated
for 1 h in the presence of the immunopurified rabbit anti-AQP1
antibody (1:200). Kidney sections were washed three times with PBS
before 1 h incubation with Cy3-conjugated goat anti-rabbit IgG
antibody. After three washes with PBS, the sections were mounted in
1:1 Vectashield:Tris HCl 0.1 mM pH 8.0 solution. Immunofluores-
cence images were taken using a 20  0.65 NA objective lens
installed on an epifluorescence microscope (Nikon Eclipse E800)
equipped with a Hamamatsu Orca CCD camera and using IPLab
spectrum software (BD Biosciences). For each kidney section, more
than 10 images of the cortex, outer stripe, and papilla were taken. All
images were analyzed using IPLab Spectrum software (BD Bio-
sciences). Thus the apical membrane fluorescence of 30–50 tubules
from each part of the kidney was studied. The maximal exposure time
was set at 100 ms to avoid pixel saturation in the papilla, and each
subsequent image was taken with this identical exposure time setting.
The mean apical pixel intensity of AQP1 fluorescence is reported as
the background-subtracted pixel intensity to the total apical mean
pixel intensity.
SDS-PAGE and Western blot analysis of rat kidney membrane
preparations. After treatment as described above, rats were anes-
thetized with isofluorane, and kidneys were harvested. Kidneys
were homogenized in cold hypotonic buffer (Tris  HCl pH 7.4, 3
mM MgCl2, and 1 mM EDTA containing complete protease
inhibitor cocktail; Roche Applied Science). Homogenized kidney
Fig. 4. Real-time PCR indicates that hypertonicity has a biphasic effect on
AQP1 mRNA regulation. IRPTC were incubated with various NaCl concen-
trations: control isotonic (CT 150 mM), low salt (LS  90 mM), and high
salt (HS 220 mM) for 12 h. AQP1 mRNA expression was also studied in the
presence of mannitol (M; 440 mosM/l) as well as high salt plus ANG II
(108M; HS  ANG II). Relative AQP1 mRNA content measured by
real-time RT-PCR was expressed as a function of AQP1 mRNA level under
isotonic conditions (CT). AQP1 mRNA expression is significantly decreased in
the low-salt condition and significantly increased in the high-salt condition.
Both mannitol and HS  ANG II conditions significantly increased AQP1
mRNA vs. control. Data are means  SE. *P  0.001.
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tissue preparations were centrifuged at 100 g for 10 min at 4°C. The
supernatants were then recentrifuged for 30 min at 35,000 g at 4°C.
Pellets were resuspended in RIPA buffer containing protease inhibitor
cocktail and stored at 80°C. The solubilized protein concentrations
were determined using the BCA protein assay, and 35 g were
separated by SDS-PAGE and analyzed by Western blot as described
above. Images were taken using a UVP bioimaging system (LLC
Upland) instead of Biomax XAR film. After exposure, the membrane
was acid stripped with 0.2 M glycine-HCl pH 2.5, Tween 0.05% for
1 h and reincubated with mouse anti-actin antibody (0.1 g/ml;
Chemicon International) and a HRP-conjugated donkey anti-mouse
antibody (0.8 g/ml; Jackson ImmunoResearch) as loading control.
The band intensities from digitalized images were quantified using
IPlab Spectrum software (BD Biosciences).
Statistics. One-way ANOVA with Bonferroni corrections was per-
formed on the relative intensity values of fluorescence images using
StatView. Analytic comparisons of mRNA expression levels were
also done using the StatView (Brainpower, Calabasas, CA). Signifi-
cance levels were set at P  0.05.
RESULTS
ANG II increases AQP1 expression in an AT1R-dependent
manner in IRPTC. After 1 and 6 h of exposure to ANG II,
AQP1 mRNA expression was not significantly changed (P 
0.05 n  4; data not shown). In contrast, a marked dose-
dependent upregulation of expression was detectable after 12 h
of exposure to ANG II (P  0.001; n  4; Fig. 1) with a
maximum effect at 108 M ANG II. To determine whether
AT1R or AT2R was involved in this process, cells were
exposed to the selective AT1R blocker losartan at 105 M
before 108 M ANG II treatment for 12 h. As shown in Fig. 2,
losartan prevented the increase in AQP1 mRNA expression.
Fig. 5. Confocal microscopy reveals AQP1 staining intensity
decreases in low-salt and increases in high-salt conditions.
A–D: maximum projection and XZ slice (taken at the white
line) of three-dimensional reconstructions of IRPTC incubated
in low salt (90 mM NaCl; A and C) or high salt (220 mM NaCl;
B and D) for 12 h. The Z projections reveal a decrease of AQP1
(red) staining on both apical regions [above the zonula occlu-
dens-1 (green) staining] as well as in basolateral membranes in
the presence of low salt and an increase in these regions in the
presence of high salt. Staining intensity of AQP1 in a single
midnuclear confocal plane is illustrated for IRPTC treated with
low salt (E) or cells treated with high salt (F) for 12 h.
G: densitometric quantification revealed that membrane fluo-
rescence was lower in cells treated with low salt and higher in
cells treated with high salt compared with untreated (CT) cells
(see also Fig. 3E). Data are means  SE; n  3. *P  0.05.
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Addition of the AT1R antagonist alone significantly decreased
AQP1 mRNA (P 0.001; n 4), whereas the selective AT2R
antagonist PD123319 (10 M) showed no significant effect
(data not shown).
The effect of ANG II on AQP1 protein levels was deter-
mined using indirect immunofluorescence in IRPTC. Cells
treated with ANG II showed an increase in staining intensity
compared with untreated cells as assessed by both single plane
confocal images as well as 3D reconstruction (Fig. 3, A and E,
respectively). Densitometric analysis of single confocal planes
showed a twofold increase in AQP1 membrane fluorescence
(Fig. 3G). Using zonula occludens-1 (a tight junction marker)
staining to delimit apical from basolateral membrane domains
in 3D reconstructions (Fig. 3, C and D), we observed in
respective z-series images that ANG II increased AQP1 ex-
pression in both apical and basolateral poles of the cell (Fig.
3D). In the basal state, the AQP1 immunofluorescence ap-
peared primarily in the basolateral plasma membrane. There
was also some labeling of cytoplasmic vesicles localized on the
subapical cytoplasmic-facing surface of the membrane (Fig.
3C). This finding is consistent with previous reports (51, 54) on
proximal tubule cells in the intact kidney. In the presence of
ANG II, an increase of immunofluorescence staining in the
perinuclear cytoplasmic region was also observed (Fig. 3, B
and F). This area is generally associated with the rough
endoplasmic reticulum and Golgi and might, therefore, contain
newly synthesized AQP1 channels. The increase in AQP1
protein expression is supported by Western blot analysis of the
IRPTC treated with ANG II (108 M), which shows a signif-
icant increase of AQP1 expression (see Fig. 6).
Hypertonicity increases AQP1 expression. To assess whether
AQP1 is sensitive to alterations of sodium, IRPTC were incubated
with various NaCl concentrations: isotonic conditions (150 mM
NaCl), low salt (90 mM NaCl), high salt (220 mM NaCl), and
mannitol (440 mM). After 12 h in low-salt conditions, AQP1
mRNA was significantly downregulated (P  0.001; n  4). In
contrast, AQP1 mRNA was increased twofold under high-salt
conditions (P  0.001; n  4; Fig. 4). Hypertonicity modulates
AQP1 expression, since mannitol also significantly increased
AQP1 mRNA expression twofold compared with control (P 
0.01; n  4; Fig. 4). Also, addition of ANG II (108 M) under
high-salt conditions did not further increase AQP1 mRNA ex-
pression, suggesting no additive effects of these two stimuli. (Fig.
4; P 0.01). We also assessed AQP1 immunostaining in the cells
incubated for 12 h in different NaCl concentrations. Single plane
images and 3D reconstruction showed an increase of AQP1
staining (Fig. 5, F and B, respectively), whereas a decreased
staining intensity occurred in cells incubated in low-salt condi-
tions (Fig. 5, E and A, respectively). Densitometric analysis of
single confocal planes showed that AQP1 membrane staining was
increased fourfold by high salt (P  0.05; n  4), while it was
slightly decreased in low salt (Fig. 5G). 3D reconstructions
showed an increase of AQP1 staining in both apical and basolat-
eral poles of high-salt-treated cells and a reduction in both poles of
AQP1 in low-salt-treated cells (Fig. 5, D and C, respectively).
Western blot analysis in cells treated with high salt and low salt
confirmed these findings: an increase of AQP1 expression in
hypertonic medium and a diminution of AQP1 expression in
hypotonic solution (Fig. 6).
ANG II affects AQP1 expression in an AT1R-dependent
manner in rat kidney tubules. The rats infused with ANG II had
a significantly higher blood pressure (161 15 mmHg/kg; n
3) than those infused with solvent alone (sham; 109  11
mmHg/kg; n  3) or rats fed with the ANG II antagonist
(103 4 mmHg/kg; n 3; P 0.01, t-test). After 10 days, the
serum osmolarity of each of the three groups was slightly
reduced from 284  5 to 269  3 mmHg/kg.
A significant difference in blood osmolality was found between
ANG II-treated rats and controls (272  1 vs. 267  1; n  3;
P  0.01). ANG II-treated rats had significantly lower urine
osmolarity after 10 days treatment than at day 0 (1,785 389 vs.
1,613  408 mmHg/kg; n  3; P  0.05), while no significant
difference was observed in sham-operated controls (2,025  166
vs. 2,243  78 mmHg/kg; n  3) and antagonist-infused rats
(2,209  309 vs. 2,197  125 mmHg/kg; n  3; Fig. 7A). The
most potent effect of ANG II was observed after the first day of
Fig. 6. Western blot analysis shows that ANG II and hypertonicity increase AQP1
expression in IRPTC. A: IRPTC were treated for 12 h in isotonic media in the
absence (lanes 1 and 2) or presence of ANG II (108M; lanes 3 and 4), as well as
in high-salt (220 mM NaCl; lanes 4 and 5) or low-salt (90 mM NaCl; lanes 7 and
8) conditions. Whole cell homogenates were separated by SDS-PAGE, and AQP1
was detected by Western blot using an anti-AQP1 antibody. Each condition was
performed in duplicate. This Western blot analysis represents 3 independent
experiments. After exposure, the blots were acid stripped and reincubated with a
pan-actin antibody as a protein loading control. B: densitometric analysis of the
combined intensity of the 28-kDa nonglycosylated AQP1 band and the glycosy-
lated band at 35–45 kDa showed that ANG II and the high-salt condition increase
AQP1 expression, while low salt resulted in a reduction of the AQP1 expression.
Data are means  SD; n  3. *P  0.05.
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treatment when urine volume increased by 158% and osmolarity
was reduced by 44%. This effect of ANG II on urine osmolarity
seems to be attenuated after day 2, when the reduction of urine
osmolarity was 20% , and it then stabilized around 10% reduction
up to the end of the treatment. This effect of ANG II was not seen
in the rats treated with ANG II and the ANG II antagonist.
Interestingly, urine volume increased a few days after ANG II
treatment (Fig. 7B), while water intake of the ANG II-treated rats
was reduced the first day and increased on the second day (Fig.
7C). ANG II-treated rats lost significant weight in the few days of
the treatment but then gained it back rapidly thereafter (Fig. 7D).
These variations in water intake, urine volume, and weight were
not observed in untreated rats and rats treated with olmesartan
(Fig. 7, B–D).
The effect of rat ANG II infusion on AQP1 kidney expres-
sion was examined by immunocytochemistry (Fig. 8). Insets
show the usual bright AQP1 staining that is normally observed
(54) in the cortex (Fig. 8A), S3 segment (Fig. 8E), and papilla
(Fig. 8I). For the quantification, we reduced the antibody
concentration to reach a linear, nonsaturated range of staining
in all sections from rats with and without ANG II treatment. An
increase of AQP1 expression in apical and basolateral mem-
branes was observed in the presence of ANG II in the cortex
(Fig. 8B) and in the papilla (Fig. 8J) compared with the control
rats (Fig. 8, A and I, respectively). A small increase in AQP1
fluorescence in apical and basolateral membranes of the S3
segment was also found in the presence of ANG II (Fig. 8F) vs.
S3 segments from control rats (Fig. 8E). This increase of AQP1
expression in ANG II-infused rat kidney was abolished by the
selective AT1R antagonist olmesartan in the cortex (Fig. 8C),
S3 segment (Fig. 8G), and papilla (Fig. 8K). Semiquantitative
immunocytochemical analysis of sections from ANG II-in-
fused rat kidneys (Fig. 8, D, H, and L) also showed two times
more AQP1 in cortical proximal tubules (Fig. 8D) and the
TDLH (Fig. 8L) than in control rats (Fig. 8, D and L).
However, ANG II treatment did not have a significant effect on
AQP1 expression in proximal tubule segment 3 (Fig. 8H)
compared with the control (Fig. 8H). This increase of AQP1
expression in ANG II-infused rat kidney was abolished by the
selective AT1R antagonist olmesartan in the cortex (Fig. 8D),
S3 segment (Fig. 8H), and papilla (Fig. 8L).
Western blot analysis of whole kidney membrane preparations
did not show a significant increase in AQP1 expression in ANG
II-treated rat kidneys, and treatment with olmesartan, the ANG II
antagonist, showed a marginal reduction of AQP1 expression
compared with ANG II-treated rats (P  0.053; Fig. 9).
DISCUSSION
The present study demonstrates that ANG II influences the
expression of the water channel AQP1 both in vitro and
in vivo. Our data on IRPTC demonstrate that AQP1 mRNA
and protein levels can be modulated directly by ANG II via the
AT1R. A role for ANG II on AQP1 expression is also sug-
gested by several previous studies. Wintour et al. (67) demon-
strated that exogenous infusion of ANG I into the jugular vein
of fetal sheep for 3 days during the last trimester increased
Fig. 7. ANG II affects urine osmolarity, urine volume, and water intake in
vivo. Rats with minipumps that deliver either sham solution (closed bar) or 80
ng of ANG II per min (opened and hatched bars) were put into metabolic
cages. Some rats were fed with olmesartan (hatched bars), an ANG II
antagonist. For 10 days, 24-h urine osmolarity (A), urine volume (B), water
intake volume (C), and rat weight (D) were measured, and these values were
compared with the 24 h metabolic baseline value of rats (day 0). Each bar
represents an average of 3 rats  SD (n  3; *P  0.05, t-test).
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intrarenal AQP1 mRNA expression in the fetal kidney, pre-
sumably via conversion of the infused ANG I to ANG II. In
other studies, Klein et al. (34) demonstrated impaired urinary
concentration associated with reduced intrarenal AQP1 expres-
sion in mice lacking ACE. While several other studies (17, 27,
34, 38, 63) employing ACE inhibitors and selective AT1R
antagonists suggested a role for ANG II in AQP1 expression,
they did not provide direct evidence for such an action of ANG
II. Our present data now show that ANG II directly affects
AQP1 expression in vitro and, importantly, show that ANG II
infusion also regulated AQP1 membrane expression in proxi-
mal tubules in vivo. These observations are consistent with a
large body of evidence indicating that ANG II is involved in
H, sodium, bicarbonate, and water transport in the proximal
tubule (8, 21, 43, 48, 55, 58).
In addition, the effects of ANG II on water and salt reab-
sorption by the proximal tubule are both dose dependent and
biphasic; low concentrations (1012 to 108 M) stimulate
sodium and water reabsorption, whereas high doses of ANG II
(107 to 105 M) appear to have inhibitory effects (4, 8, 10,
20, 42, 58). In the present studies, 108 M ANG II increased
both AQP1 mRNA and protein levels after 12 h of exposure.
The increases in AQP1 mRNA induced by ANG II were
inhibited by losartan, implicating the AT1R as the mediator of
the response, which is also consistent with actions on sodium
and bicarbonate transport.
The AQP1 protein was detected in IRPTC by Western
blotting and immunostaining. Immunofluorescence results in-
dicate that the AQP1 protein is inserted into the plasma
membrane without significant accumulation in an intracellular
Fig. 8. ANG II increases AQP1 immunofluorescence staining in rat kidneys in vivo, and an AT1R antagonist inhibits this effect. AQP1 immunostaining was
performed on paraffin-embedded rat kidney sections. Sections from normal rats (A, E, and I), ANG II (108 M)-infused rats (B, F, and J), and ANG II (108
M)- and olmesartan (105 M)-infused rats (C, G, and K) were incubated with a low concentration of anti-AQP1 antibody. All images were acquired using
identical exposure times. AQP1 expression in cortex (A–C), S3 proximal tubule segments (PTs; E–G), and papilla (I–K) was compared, and a densitometric
analysis showed an increase of AQP1 staining in proximal tubule segments 1 and 2 (D) and in thin descending limb of Henle (L) but not in the PT S3 segment
(H). Note that to obtain a linear, nonsaturated range of staining in all sections from rats with and without ANG II treatment, the antibody concentrations used
to generate these figures was reduced so that PTs from normal control rats were stained more weakly than is normally observed (54). Examples of the usual bright
AQP1 staining in PTs of normal rats using an optimal antibody concentration and exposure times are illustrated for comparison in insets of A, E, and I. AQP1
staining is more abundant in PTs (B) and in thin descending limb of Henle (J) in animals treated with ANG II compared with rats not treated with the octapeptide
(A and I, respectively). The pattern of AQP1 staining in kidneys of animals infused with ANG II plus olmesartan is similar to that in untreated rats. Images of
rat kidney sections are representative of images obtained with animals treated under similar conditions (6 per group). Fluorescence intensity of 20 cells from each
kidney sections were quantified. Data are means  SD; n  6. *P  0.05, one-way ANOVA (G: glomerulus in A and insets).
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compartment. The levels of membrane-associated AQP1 de-
tected by immunocytochemistry and Western blot increased
12 h after ANG II (108 M) stimulation. However, aside from
intensity levels, no qualitative difference in the staining pattern
between stimulated and control cells could be detected, and no
evidence of a regulated shuttle mechanism for the membrane
insertion of AQP1, such as that seen for the collecting duct
water channel AQP2, was detectable (14, 18, 33, 50, 53).
Signaling pathways for ANG II within the proximal tubule are
complex and numerous, and the specific mechanism by which
ANG II affects AQP1 expression is currently not known.
Torres et al. (64) showed in 1978 that ANG II inhibits adenylyl
cyclase within the proximal tubule. Since then, several studies
(28, 43) have suggested that ANG II stimulates sodium trans-
port by inhibiting adenylyl cyclase. However, several cAMP-
independent pathways have also been reported, such as acti-
vation of phospholipase A2 (15) and activation of phospho-
lipase C (8). cAMP upregulates expression of AQP2, and
cAMP-responsive elements have been detected in the 5	-
flanking region of the AQP2 gene (26). Using a Xenopus
oocyte expression system, Yool et al. (70) showed regulation
of AQP1 permeability via a cAMP-dependent mechanism. In
their experiments, forskolin induced a cation current in AQP1-
expressing oocytes. However, other laboratories (2, 13, 66)
could not reproduce those results. However, other work pub-
lished by Anthony and collegues reported that AQP1 not only
mediates water flux but also serves as a cGMP-gated ion
channel (3) or CO2 transport (11, 16).
The present studies, using an in vitro system of immortalized
rat proximal tubular cells, demonstrate that AQP1 mRNA and
protein are upregulated by extracellular hypertonicity for 12 h,
possibly via transcriptional activation or posttranscriptional regu-
lation such as increased mRNA stability. Hypertonicity-induced
AQP1 expression involves the MAPK pathway and the hyperto-
nicity-responsive element (65). Previous studies have clearly
shown that AQP2 expression and trafficking are also regulated by
tonicity (6, 24, 25, 60) and that increased membrane accumulation
of AQP2 in response to hypertonicity is MAPK dependent (25).
However, Leitch et al. (40) showed that the increase in AQP1
protein expression induced by hypertonic stress was due to re-
duced protein ubiquitination and increased protein stability.
Abrami et al. (1) demonstrated that salt acclimation increased
expression of the water channel FA-CHIP-mRNA, an aquaporin
of the frog urinary bladder, using the model of toad skin and
urinary bladder. Similar observations followed using epithelial
cell cultures (29, 30). In our studies, addition of ANG II (108 M)
to cells incubated in high-salt conditions (220 mM) did not further
increase AQP1 mRNA expression.
The concentration of salt in the interstitial fluid varies along
the renal cortico-medullary axis. This gradient is necessary for
the urinary concentrating mechanism to function but also has
significant effects on the responsiveness of cells to an antidi-
uretic hormone (71). Cells in the inner medulla are exposed to
variable and high levels of NaCl and undergo adaptive re-
sponses (7, 49). Most cells are normally not stressed by
hypertonicity, because the concentration of NaCl is closely
controlled in all extracellular body fluid compartments, the
kidney medulla being a remarkable exception. This implies
that ANG II rather than osmolality is likely to be more
important in regulating AQP1 levels in the proximal tubule. In
the present study, AQP1 mRNA is downregulated in IRPTC in
response to low salt; this mechanism might play an important
role in chronic intracellular volume regulatory mechanisms.
Proximal renal tubule cells may adjust intracellular volume in
hypotonic extracellular media owing not only to loss of solute
but also through chronic modulation of AQP1. Whether a
Fig. 9. A: Western blot analysis of AQP1 expression in
control and ANG II-treated rat kidney. Rats were treated 10
days with minipumps delivering vehicle alone (control) or
80 ng of ANG II per min. Membrane kidney homogenates
were separated by SDS-PAGE, and AQP1 was detected by
Western blot using an anti-AQP1 antibody. Each condition
was performed in 3 rats. After exposure, the blot was
acid-stripped and reincubated with a pan-actin antibody as
a protein loading control. B: densitometric analysis of the
combined intensity of the 28-kDa nonglycosylated AQP1
band and the glycosylated band at 35–45 kDa showed that
ANG II slightly increased AQP1 expression while olme-
sartan resulted in a reduction of AQP1 expression. Data are
means  SD; n  3.
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similar mechanism occurs in the cells of the TDLH remains to
be determined, but this segment is certainly exposed to varia-
tions in extracellular osmolality to a greater extent than are
cells of the proximal convoluted tubule in the cortex.
Our in vivo study showed that in the kidney, ANG II is an
important agent in volume-mediated fluid expansion, which reg-
ulates long-term arterial pressure as proposed by Guyton (19),
who suggested that dysregulation of body fluid volume is a
requisite for the pathogenesis of hypertension. The ANG II-
infused rats have high blood pressure, higher urinary volume,
decreased urinary osmolarity, increased fluid intake and signifi-
cant weight gain due to volume expansion, suggesting increased
sodium and water reabsorption. Whole kidney AQP1 expression
was not measureably increased in the ANG II-infused animals but
was significantly decreased by AT1R antagonist (olmesartan)
treatment. Although total kidney AQP1 was not increased, we
quantified a twofold increase of AQP1 fluorescence intensity in
the proximal tubule and TDLH in the ANG II-infused rats,
suggesting a redistribution of AQP1 expression that affected the
staining intensity, perhaps reflecting an increase in membrane
localization similar to our finding in cultured cells. This twofold
increase in proximal tubule and TDLH fluorescence intensity was
abolished by the AT1R antagonist (olmesartan). We suggest that
ANG II increases AQP1 expression in vitro and in vivo via AT1R.
Nevertheless, the effect of ANG II on TDLH may be indirect
because we are assuming that TDLH cells also express the AT1R.
It is possible that AT1R in TDLH may be expressed at a level that
was not detectable in prior studies. However, ANG II treatment
has little if any effect on AQP1 expression in the S3 segment
where AT1R is known to be expressed (46). It is possible that the
constant presence of ANG II led to a partial desensitization of
AT1R, while such an effect of ANG II was not observed in other
tubule areas with lower AT1R abundance, such as the S1 segment
or TDLH (9). Nevertheless, our findings support a critical renal
role of ANG II in volume expansion and volume hypertension
mediated by the AT1R. Similar results showing the key roles of
RAS mediated by AT1R in the kidney in volume regulation were
demonstrated by Crowley et al. (12) using kidney AT1R vs.
systemic knockout models.
In summary, our data demonstrate that AQP1 mRNA and
protein levels in proximal tubule cells can be regulated in vitro by
NaCl and ANG II. Due to the relatively stable isotonic environ-
ment in the renal cortex, the regulation of AQP1 in this segment
is unlikely through hypertonicity. Our results showing that AQP1
is upregulated in proximal cells in culture (IRPTC) and in PT cells
in vivo by ANG II, and that this effect is mediated by AT1R,
provide strong evidence in favor of a physiological role for the
RAS in this process. In contrast, regulation of AQP1 expression in
the medulla (cells of the TDLH) could occur mainly as a response
to interstitial NaCl concentration, although a role for ANG II in
this tubule segment is also possible.
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